This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This VAPA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 182-210 amino acids from the C-terminal region of human VAPA.
VAPA
Reactivity: Human
IP
Host: Rabbit
Polyclonal
unconjugated
Application Notes
For WB starting dilution is: 1:1000
Restrictions
For Research Use only
Format
Liquid
Concentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
VAPA
(VAMP (Vesicle-Associated Membrane Protein)-Associated Protein A, 33kDa (VAPA))
VAP-33 antibody, VAP-A antibody, VAP33 antibody, hVAP-33 antibody, 33kDa antibody, wu:fa14e12 antibody, zgc:65776 antibody, zgc:77382 antibody, VAMP associated protein A antibody, vesicle-associated membrane protein, associated protein A antibody, VAMP (vesicle-associated membrane protein)-associated protein A antibody, VAPA antibody, Vapa antibody, vapa antibody
Background
The protein encoded by this gene is a type IV membrane protein. It is present in the plasma membrane and intracellular vesicles. It may also be associated with the cytoskeleton. This protein may function in vesicle trafficking, membrane fusion, protein complex assembly and cell motility. Alternative splicing occurs at this locus and two transcript variants encoding distinct isoforms have been identified.